Integrating patient centricity into the Menarini mature brand strategy for commercial excellence
Menarini worked with Clarivate to build more patient-centric approaches for its established brands in the Asia Pacific region, addressing industry-wide challenges around generating fresh real-world evidence and effectively engaging healthcare professionals. Using a validated patient journey mapping framework, the team identified care gaps and engagement opportunities and incorporated behavioral and emotional patient factors into commercial strategy. This resulted in improved patient outcomes and increased brand awareness in APAC. The case study addresses questions such as how to generate new evidence for established brands and identify patient journey gaps in chronic pain management, but no specific quantitative outcomes are given in the visible page content.
Clarivate owns Cortellis, the curated competitive-intelligence and pipeline-tracking platform standard in pharma portfolio-management teams.
This sits in the Data Providers stage of the AI use-case lifecycle: Named examples from the real-world-data, claims and competitive-intelligence providers pharma AI systems are trained on, benchmarked against, or run inside of.
Published by Clarivate on its own site — read the original case study on clarivate.com ↗
Related use cases
- 01How Bioventus evolved their commercial strategy with real world data and intelligence
- 02Clarivate and CLEO diagnostics are making early detection of ovarian cancer a reality
- 03Making informed investment decisions (Attracting breakthrough innovations from academic research) - SPRIND case study
- 04Gedeon Richter — Case study | Clarivate Regulatory Intelligence Tracking Application
- 05Artificial Intelligence in Pharmacovigilance: Using AI to help GSK detect ICSRs in scientific literature
- 06Monitoring the rare diseases landscape